论文部分内容阅读
目的研究血塞通治疗脑梗塞的疗效。方法病例资料来源于我院2014年2月~2015年6月就诊的70例脑梗塞患者。随机进行分组,70例患者分为对照组和观察组。对照组采取常规药物治疗;观察组在对照组基础上增加血塞通治疗。比较(1)临床总治疗效率;(2)干预前和干预后患者神经功能缺损评分、日常生活能力评分、血浆纤维蛋白原、血浆黏度、红细胞压积、红细胞聚集指数的差异。结果 (1)观察组对比对照组临床总治疗效率更高,P<0.05;(2)干预前两组神经功能缺损评分、日常生活能力评分、血浆纤维蛋白原、血浆黏度、红细胞压积、红细胞聚集指数相似,P>0.05;干预后观察组对比对照组神经功能缺损评分、日常生活能力评分、血浆纤维蛋白原、血浆黏度、红细胞压积、红细胞聚集指数改善更显著,P<0.05。结论血塞通治疗脑梗塞的疗效确切,可有效改善患者血液流变学指标,降低神经功能缺损程度,提升患者日常生活能力,值得推广。
Objective To study the efficacy of Xuesaitong in treating cerebral infarction. Methods The data of the cases were from 70 patients with cerebral infarction treated in our hospital from February 2014 to June 2015. Randomly divided into groups, 70 patients were divided into control group and observation group. Control group to take conventional drug treatment; observation group in the control group based on the increase of Xuesaitong treatment. (1) The total clinical curative efficiency; (2) The difference of neurological deficit score, daily living ability score, plasma fibrinogen, plasma viscosity, hematocrit and erythrocyte aggregation index before and after intervention. Results (1) The total clinical curative efficiency of the observation group was significantly higher than that of the control group (P <0.05). (2) The neurological deficit score, daily living ability score, plasma fibrinogen, plasma viscosity, hematocrit, P <0.05. After intervention, the neurological deficit score, daily living ability score, plasma fibrinogen, plasma viscosity, hematocrit, and erythrocyte aggregation index in the observation group were significantly improved after intervention (P <0.05). Conclusion Xuesaitong treatment of cerebral infarction exact effect, which can effectively improve the patient’s blood rheology indicators, reduce the degree of neurological deficits and enhance the ability of patients with daily living, it is worth promoting.